Status:

WITHDRAWN

Comparison of Intravenous Omeprazole to Ranitidine on Recurrent Bleeding After Endoscopic Treatment of Bleeding Ulcer

Lead Sponsor:

Keio University

Conditions:

Peptic Ulcers

Eligibility:

All Genders

20-80 years

Phase:

PHASE4

Brief Summary

The present study will compare the hemostasis-maintaining effects of intravenous omeprazole and ranitidine in patients with upper gastrointestinal hemorrhage that have undergone endoscopic hemostasis,...

Detailed Description

Gastrointestinal hemorrhage is a relatively common condition, with the source of the bleeding being most commonly from the upper gastrointestinal tract, especially from gastric and duodenal ulcers. It...

Eligibility Criteria

Inclusion

  • Patients with identified gastric or duodenal ulcer
  • Patients with hemorrhagic exposed vessel at the ulcer lesion, oozing or projectile hemorrhage (predominantly arterial) from the ulcer, and where endoscopic hemostasis has been performed.
  • Over 20 years of age of either sex.
  • The subject or his or her proxy consenter has provided written informed consent.

Exclusion

  • Serious hepatopathy, nephropathy, or heart disease.
  • Complicating malignant tumor.
  • Hemorrhage from malignant tumor.
  • The patient is on, or in need of, treatment with a drug considered to interact with the test drug.
  • History of allergy to the test drug.
  • History of anaphylactic shock.
  • Pregnant, possibly pregnant, or lactating.
  • patient who is unable to fully understand the explanation about the study.
  • patient who is judged by the investigator to be otherwise inappropriate for inclusion.

Key Trial Info

Start Date :

October 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 1 2007

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00247130

Start Date

October 1 2005

End Date

July 1 2007

Last Update

April 3 2015

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Department of Internal Medicine, Keio University School of Medicine

Tokyo, Tokyo, Japan, 1608582